Aselizumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized (from mouse) |
| Target | CD62L |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
 N Y (what is this?) (verify) | |
Aselizumab is an immunosuppressive drug which has been investigated for the use in severely injured patients. It binds to CD62L.[1]
References
- ↑ Seekamp A, van Griensven M, Dhondt E, Diefenbeck M, Demeyer I, Vundelinckx G, et al. (October 2004). "The effect of anti-L-selectin (aselizumab) in multiple traumatized patients--results of a phase II clinical trial". Critical Care Medicine. 32 (10): 2021–8. doi:10.1097/01.CCM.0000142396.59236.F3. PMID 15483410. S2CID 21172224.
Monoclonal antibodies for the immune system | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Immune system |
| ||||||||||
| Interleukin |
| ||||||||||
| Inflammatory lesions |
| ||||||||||
| |||||||||||
Categories:
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Short description is different from Wikidata
- Articles with changed CASNo identifier
- Chemicals that do not have a ChemSpider ID assigned
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugs that are a monoclonal antibody
- All stub articles
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.